北京市医疗保障局 北京市人力资源和社会保障局关于调整B型钠尿肽(BNP)测定等医疗服务价格项目和相关政策的通知

English title (machine-translated)
The Beijing Municipal Bureau of Medical Security and the Beijing Municipal Bureau of Human Resources and Social Security Notification on Adjusting the Prices of Medical Services Including B-type Natriuretic Peptide (BNP) Testing and Related Policies.
Published
2024-10-31
Type
Law, regulation or policy
Subtype
规范性文件
Level
北京市 (Provincial-level units)
Length
655 characters, 12 paragraphs
Department
北京市医疗保障局
Law Status

Summary

(1)  The Beijing Municipal Bureau of Health Insurance has issued a notice regarding adjustments to certain medical service prices and related policies. The notice states that 19 medical service prices, including "B-type natriuretic peptide (BNP) measurement," will be adjusted to the highest guidance prices, which cannot be exceeded, and can be reduced by any amount. The report also clarifies the categories of reimbursement for basic medical insurance and workers' compensation insurance (see Annex 1 and Annex 2).

(2)  At the same time, 48 existing medical service prices, including "Wechsler screening method examination," will be abolished (see Annex 3). Public hospitals must provide services and charge fees strictly in accordance with the price policy and clinical treatment standards, and cannot charge fees not listed. Public hospitals must establish and improve their internal price management systems, strictly regulate their own price behavior, and strictly implement the medical service price publicizing system.

(3)  This system requires public hospitals to publicize medical service projects, prices, and service standards in a prominent location through various means, and to implement the inpatient fee list, clear pricing, and other relevant regulations. The relevant departments of the city and districts must perform their duties and fulfill their responsibilities.

(4)  They must actively promote and explain the policy, closely monitor the policy's execution, and track its implementation effects. They must also strengthen supervision and management of medical institutions, medical ethics and medical morality education, and regulate the service behavior of medical personnel to improve service quality.

(5)  In addition, they must guide medical institutions to strengthen internal cost accounting and cost control, actively perform cost control work, and promptly resolve medical disputes. The use of clinical medical and therapeutic technologies prohibited by the national or municipal health administrative department will not be subject to the city's various price policies.

(6)  This notice takes effect on November 16, 2024. In the event of any inconsistencies between previous documents and this notice, this notice shall prevail. During the policy implementation process, if new situations or new problems arise, medical institutions should report them to the relevant departments in a timely manner.

Original

(1)  京医保发〔2024〕15号

(2)  各区医疗保障局、人力资源和社会保障局,北京经济技术开发区社会事业局,各有关医疗机构:

(3)  按照国家医疗保障局有关要求,现就调整部分医疗服务价格项目和相关政策有关事项通知如下:

(4)  一、调整“B型钠尿肽(BNP)测定”等19项医疗服务价格项目,附件所列价格为最高指导价格,不得上浮,下浮幅度不限。同时,明确基本医疗保险和工伤保险报销类别(见附件1、附件2)。

(5)  二、同步废止“韦氏筛选法测查”等48项现行相关医疗服务价格项目(附件3)。

(6)  三、各公立医疗机构要严格按照价格政策规定和临床诊疗规范向患者提供服务并收取费用,不得收取未列明的费用。各公立医疗机构要建立健全内部价格管理制度,严格规范自身价格行为;严格执行医疗服务价格公示制度,在服务场所显著位置通过多种方式公示医疗服务项目、价格及服务规范等内容,落实好住院费用清单、明码标价等相关规定。

(7)  四、市、区各有关部门要各司其职,落实责任。要积极做好政策宣传解释,密切关注政策执行情况,跟踪政策实施效果;要切实加强对医疗机构的监督管理和医德医风教育,规范医务人员服务行为,不断提高服务质量;要指导医疗机构加强内部成本核算和成本控制,主动做好控费工作,及时解决医患矛盾。

(8)  五、国家或本市卫生行政主管部门禁止临床使用的医学诊疗技术,不适用本市各项价格政策。

(9)  本通知自2024年11月16日起执行。此前文件与本通知不一致的,以本通知为准。政策执行过程中出现的新情况、新问题,各医疗机构应及时报告有关部门。

(10)  北京市医疗保障局

(11)  北京市人力资源和社会保障局

(12)  2024年10月31日